Cargando…
Hepatocyte growth factor intervention to reduce myocardial injury and improve cardiac function on diabetic myocardial infarction rats
Acute myocardial infarction (AMI) is recognized to be a severe threat to people’s health conditions and life quality. The accumulation of hepatocyte growth factor (HGF) in ischemic myocardium has been observed in both processes of experimental ischemia and reperfusion (I/R) and permanent coronary ar...
Autores principales: | Zhang, Zaiyong, Long, Cheng, Guan, Yufeng, Song, Mingcai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445436/ https://www.ncbi.nlm.nih.gov/pubmed/32909423 http://dx.doi.org/10.4081/ejh.2020.3142 |
Ejemplares similares
-
CEACAM-1 promotes myocardial injury following coxsackievirus infection by regulating the coxsackievirus-adenovirus receptor
por: Zhang, Zaiyong, et al.
Publicado: (2019) -
Berberine inhibits cardiac remodeling of heart failure after myocardial infarction by reducing myocardial cell apoptosis in rats
por: Liao, Ying, et al.
Publicado: (2018) -
Cardiac Troponin Thresholds and Kinetics to Differentiate Myocardial Injury and Myocardial Infarction
por: Wereski, Ryan, et al.
Publicado: (2021) -
Impact of Hepatocyte Growth Factor on Skeletal Myoblast Transplantation Late After Myocardial Infarction
por: O’Blenes, Stacy B., et al.
Publicado: (2013) -
Prognostic tools at hospital arrival in acute myocardial infarction: copeptin and hepatocyte growth factor
por: Pintado, María-Consuelo, et al.
Publicado: (2022)